These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 26602384)
21. Down-regulated FSTL5 promotes cell proliferation and survival by affecting Wnt/β-catenin signaling in hepatocellular carcinoma. Zhang D; Ma X; Sun W; Cui P; Lu Z Int J Clin Exp Pathol; 2015; 8(3):3386-94. PubMed ID: 26045876 [TBL] [Abstract][Full Text] [Related]
22. miR-24 promotes the proliferation, migration and invasion in human tongue squamous cell carcinoma by targeting FBXW7. Zhao J; Hu C; Chi J; Li J; Peng C; Yun X; Li D; Yu Y; Li Y; Gao M; Zheng X Oncol Rep; 2016 Aug; 36(2):1143-9. PubMed ID: 27350307 [TBL] [Abstract][Full Text] [Related]
23. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway. Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274 [TBL] [Abstract][Full Text] [Related]
24. CUL4B activates Wnt/β-catenin signalling in hepatocellular carcinoma by repressing Wnt antagonists. Yuan J; Han B; Hu H; Qian Y; Liu Z; Wei Z; Liang X; Jiang B; Shao C; Gong Y J Pathol; 2015 Apr; 235(5):784-95. PubMed ID: 25430888 [TBL] [Abstract][Full Text] [Related]
25. Role of Fbxw7 expression in hepatocellular carcinoma and adjacent non-tumor liver tissue. Imura S; Tovuu LO; Utsunomiya T; Morine Y; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Yamada S; Ishikawa D; Bando Y; Shimada M J Gastroenterol Hepatol; 2014 Oct; 29(10):1822-9. PubMed ID: 24731221 [TBL] [Abstract][Full Text] [Related]
26. RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway. Wang H; Yang Z; Liu C; Huang S; Wang H; Chen Y; Chen G Biochem Biophys Res Commun; 2014 Nov; 454(1):71-7. PubMed ID: 25445601 [TBL] [Abstract][Full Text] [Related]
27. miR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and suppressing Wnt/β-catenin signaling pathway. Zhang JJ; Chen JT; Hua L; Yao KH; Wang CY Biomed Pharmacother; 2017 Jan; 85():472-478. PubMed ID: 27890434 [TBL] [Abstract][Full Text] [Related]
28. Integrin-β5, a miR-185-targeted gene, promotes hepatocellular carcinoma tumorigenesis by regulating β-catenin stability. Lin Z; He R; Luo H; Lu C; Ning Z; Wu Y; Han C; Tan G; Wang Z J Exp Clin Cancer Res; 2018 Jan; 37(1):17. PubMed ID: 29386044 [TBL] [Abstract][Full Text] [Related]
29. miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7. Zhou C; Shen L; Mao L; Wang B; Li Y; Yu H Biochem Biophys Res Commun; 2015 Feb; 458(1):63-9. PubMed ID: 25623537 [TBL] [Abstract][Full Text] [Related]
30. MiR-342 regulates cell proliferation and apoptosis in hepatocellular carcinoma through Wnt/β-catenin signaling pathway. Lu C; Jia S; Zhao S; Shao X Cancer Biomark; 2019; 25(1):115-126. PubMed ID: 31006667 [TBL] [Abstract][Full Text] [Related]
31. Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/β-catenin signaling in human hepatocellular carcinoma. Zeng XC; Liu FQ; Yan R; Yi HM; Zhang T; Wang GY; Li Y; Jiang N Mol Cancer; 2014 Dec; 13():261. PubMed ID: 25491321 [TBL] [Abstract][Full Text] [Related]
32. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin. Wang X; Chen J; Li F; Lin Y; Zhang X; Lv Z; Jiang J Biochem Biophys Res Commun; 2012 Nov; 428(4):525-31. PubMed ID: 23068095 [TBL] [Abstract][Full Text] [Related]
33. The effect of cell cycle and expression of cyclin B1 and cyclin C protein in hepatocellular carcinoma cell line HepG2 and SMMC-7721 after of silencing β-catenin gene. Wang B; Xunsun ; Liu JY; Yang D; Yang LL; Kong DX; Meng XW Hepatogastroenterology; 2012; 59(114):515-8. PubMed ID: 22024040 [TBL] [Abstract][Full Text] [Related]
34. miR-885-5p suppresses hepatocellular carcinoma metastasis and inhibits Wnt/β-catenin signaling pathway. Zhang Z; Yin J; Yang J; Shen W; Zhang C; Mou W; Luo J; Yan H; Sun P; Luo Y; Tian Y; Xiang R Oncotarget; 2016 Nov; 7(46):75038-75051. PubMed ID: 27738331 [TBL] [Abstract][Full Text] [Related]
35. The FBXW7 beta-form is suppressed in human glioma cells. Gu Z; Inomata K; Ishizawa K; Horii A Biochem Biophys Res Commun; 2007 Mar; 354(4):992-8. PubMed ID: 17274947 [TBL] [Abstract][Full Text] [Related]
36. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma. Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186 [TBL] [Abstract][Full Text] [Related]
37. The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway. Chen J; Rajasekaran M; Xia H; Zhang X; Kong SN; Sekar K; Seshachalam VP; Deivasigamani A; Goh BK; Ooi LL; Hong W; Hui KM Gut; 2016 Sep; 65(9):1522-34. PubMed ID: 26941395 [TBL] [Abstract][Full Text] [Related]
38. FBW7 increases chemosensitivity in hepatocellular carcinoma cells through suppression of epithelial-mesenchymal transition. Yu J; Zhang W; Gao F; Liu YX; Chen ZY; Cheng LY; Xie SF; Zheng SS Hepatobiliary Pancreat Dis Int; 2014 Apr; 13(2):184-91. PubMed ID: 24686546 [TBL] [Abstract][Full Text] [Related]
39. Crosstalk between liver-related microRNAs and Wnt/β-catenin pathway in hepatocellular carcinoma patients. Ashmawy AM; Elgeshy KM; Abdel Salam ET; Ghareeb M; Kobaisi MH; Amin HAA; Sharawy SK; Abdel Wahab AHA Arab J Gastroenterol; 2017 Sep; 18(3):144-150. PubMed ID: 28958640 [TBL] [Abstract][Full Text] [Related]
40. WNT1 Gene from WNT Signaling Pathway Is a Direct Target of miR-122 in Hepatocellular Carcinoma. Ahsani Z; Mohammadi-Yeganeh S; Kia V; Karimkhanloo H; Zarghami N; Paryan M Appl Biochem Biotechnol; 2017 Mar; 181(3):884-897. PubMed ID: 27687586 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]